Federal Register #FDA-2011-N-0656

FDA Seeks Public Input on Animal Drug User Fee Act (ADUFA) Reauthorization

The Food and Drug Administration (FDA), under the Department of Health and Human Services, is hosting a virtual public meeting to gather input on the reauthorization of the Animal Drug User Fee Act (ADUFA) program. - Government Buyer: - Department of Health and Human Services (HHS) - Food and Drug Administration (FDA) - Purpose: - Solicit public comments and suggestions on the performance and improvement of the ADUFA program - Meeting is part of statutory requirements for ADUFA reauthorization - Products/Services Requested: - No products, OEMs, or vendors are being procured or awarded - This is a request for information and public comment only - Unique/Notable Requirements: - Public meeting is open to all stakeholders - Written and oral comments will be published on the FDA website - Input will inform the next reauthorization of the ADUFA program

Description

The Food and Drug Administration (FDA) is announcing a virtual public meeting titled "Animal Drug User Fee Act" to invite public comment on the ADUFA program and suggestions for its next reauthorization. The meeting will be held virtually on May 27, 2026, from 2 p.m. to 4 p.m. Eastern Time. Comments can be submitted throughout the reauthorization process until December 1, 2027, with comments received by July 1, 2026, suggesting changes to the program published on the FDA website. The meeting aims to gather public input on the overall performance of the ADUFA program and suggestions for improvements.

View original listing